Abiopharma

Metzger Michael A 🟡 adjusted position in 157.3K shares (1 derivative) of Syndax Pharmaceuticals Inc (SNDX) at $16.41 ($6.0M) Transaction Date: Sep 08, 2025 | Filing ID: 113659

Cuffe Michael S. 🟡 adjusted position in 10.9K shares (1 derivative) of HCA Healthcare, Inc. (HCA) at $418.84 ($8.3M) Transaction Date: Sep 04, 2025 | Filing ID: 000003

Director SHADAN MARTHA 🟢 acquired 3 shares (5 derivative) of LEMAITRE VASCULAR INC (LMAT) Transaction Date: Sep 04, 2025 | Filing ID: 028588

Director Roush John A 🟢 acquired 3 shares (5 derivative) of LEMAITRE VASCULAR INC (LMAT) Transaction Date: Sep 04, 2025 | Filing ID: 028587

Director Ross Bridget A 🟢 acquired 3 shares (5 derivative) of LEMAITRE VASCULAR INC (LMAT) Transaction Date: Sep 04, 2025 | Filing ID: 028586

Director O'Connor John James 🟢 acquired 3 shares (5 derivative) of LEMAITRE VASCULAR INC (LMAT) Transaction Date: Sep 04, 2025 | Filing ID: 028585

Kamke Trent G 🟢 acquired 9 shares (7 derivative) of LEMAITRE VASCULAR INC (LMAT) Transaction Date: Sep 04, 2025 | Filing ID: 028583

LeBlanc Dorian Paul 🟢 acquired 3 shares (1 derivative) of LEMAITRE VASCULAR INC (LMAT) Transaction Date: Sep 04, 2025 | Filing ID: 028582

Director Pellegrino Joseph P JR 🟢 acquired 19 shares (7 derivative) of LEMAITRE VASCULAR INC (LMAT) Transaction Date: Sep 04, 2025 | Filing ID: 028581

Director Roberts David B 🟢 acquired 19 shares (8 derivative) of LEMAITRE VASCULAR INC (LMAT) Transaction Date: Sep 04, 2025 | Filing ID: 028580